Effydral Tablets
Effydral Tablets
Not authorised
- Glycine
- Citric acid
- Lactose monohydrate
- Potassium chloride
- Sodium chloride
- Sodium hydrogen carbonate
Product identification
Medicine name:
Effydral Tablets
Active substance:
- Glycine
- Citric acid
- Lactose monohydrate
- Potassium chloride
- Sodium chloride
- Sodium hydrogen carbonate
Target species:
-
Cattle
Route of administration:
-
Oral use
Product details
Active substance and strength:
-
Glycine2.25/gram(s)1.00Tablet
-
Citric acid3.84/gram(s)1.00Tablet
-
Lactose monohydrate32.44/gram(s)1.00Tablet
-
Potassium chloride1.12/gram(s)1.00Tablet
-
Sodium chloride2.34/gram(s)1.00Tablet
-
Sodium hydrogen carbonate6.72/gram(s)1.00Tablet
Pharmaceutical form:
-
Effervescent tablet
Withdrawal period by route of administration:
-
Oral use
-
Cattle
-
Meat and offal0day
-
-
Anatomical therapeutic chemical veterinary (ATCvet) codes:
- QB05XA
Legal status of supply:
-
Veterinary medicinal product not subject to veterinary prescription
Authorisation status:
-
Surrendered
Authorised in:
-
Ireland
Package description:
- Aluminium tubs covered with aluminium foil containing a round, white, effervescent tablet with flat end surfaces and bevelled edges.�The diameter is about 52 mm and the height is about 19 mm.�The mean tablet weight is about 48.7 g.�One cardboard box contains 48 tablets packed in inner cartons of 6 x 8 tablets.
Additional information
Entitlement type:
-
Marketing Authorisation
Legal basis of product authorisation:
-
Complete application (stand-alone) - Council Directive 81/851/EEC
Marketing authorisation holder:
- Zoetis Belgium S.A.
Marketing authorisation date:
Manufacturing sites for batch release:
- Aurovitas Nederland B.V.
Responsible authority:
- Health Products Regulatory Authority
Authorisation number:
- VPA10387/024/001
Date of authorisation status change:
To consult adverse reactions on veterinary medicinal products please go to www.adrreports.eu/vet
Documents
Summary of Product Characteristics
English (PDF)
Download Published on: 3/05/2024